{"id":"W4387492877","doi":"10.1021/acsomega.3c05377","title":"Optimization of 3-Cyano-7-cyclopropylamino-pyrazolo[1,5- <i>a</i> ]pyrimidines toward the Development of an In Vivo Chemical Probe for CSNK2A","year":2023,"lang":"en","type":"article","venue":"ACS Omega","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Common Fund; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; National Institute of Diabetes and Digestive and Kidney Diseases; Takeda Oncology; Genentech; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Ontario Genomics Institute; European Federation of Pharmaceutical Industries and Associations; Merck KGaA; National Institutes of Health; Ontario Genomics; Genome Canada; Pfizer; Bristol-Myers Squibb; North Carolina Biotechnology Center; Bayer; McGill University; University of North Carolina at Chapel Hill; U.S. Department of Defense","keywords":"In vivo; Chemistry; Pharmacokinetics; Enzyme; Covalent bond; Pharmacology; Combinatorial chemistry; Biochemistry; Stereochemistry; Organic chemistry; Medicine; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00106557,0.0002005428,0.000346351,0.0001771659,0.00009061168,0.000008276385,0.0004586983,0.0002248629,0.00004522872],"category_scores_gemma":[0.0001301388,0.0001591221,0.00007788941,0.0005744808,0.0001665428,0.00008896158,0.0001469456,0.0002418129,0.00000588247],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002901186,"about_ca_system_score_gemma":0.0001946088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005248498,"about_ca_topic_score_gemma":0.000007742908,"domain_scores_codex":[0.9982916,0.0001339081,0.0006685928,0.0002860836,0.0001895623,0.0004302577],"domain_scores_gemma":[0.9989843,0.0003006366,0.0002284282,0.0002041184,0.0001734457,0.0001091144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003689991,0.000356556,0.001025101,0.000185792,0.00009330983,0.000002968878,0.004505108,0.01503649,0.9650479,0.0003267018,0.0007612396,0.01228983],"study_design_scores_gemma":[0.001727983,0.00004511241,0.0005525662,0.00001370268,0.00007622004,0.000002642069,0.0002773628,0.01745676,0.9593943,0.0005173371,0.01975104,0.0001849237],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959031,0.0002707022,0.001153348,0.0006687404,0.0005491994,0.0008910075,0.00008935692,0.00005415755,0.0004204139],"genre_scores_gemma":[0.9913789,0.0002674255,0.007391309,0.0003178084,0.0001387246,0.0002773541,0.00007359785,0.00003219691,0.0001226971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0189898,"threshold_uncertainty_score":0.6488811,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1161123156095529,"score_gpt":0.4087436076058137,"score_spread":0.2926312919962608,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}